The relationship between proliferative and oxygenation status in spontaneous canine tumors - PubMed (original) (raw)
The relationship between proliferative and oxygenation status in spontaneous canine tumors
E M Zeman et al. Int J Radiat Oncol Biol Phys. 1993.
Abstract
Purpose: Immunocytochemical markers have been applied to biopsy specimens from spontaneous canine tumors to assess the prevalence and spatial distribution of proliferating and hypoxic cells, and their "geographic" relationship to each other. Both types of cells have been implicated in the failure to locally control human tumors treated with radiation and chemotherapy.
Methods and materials: For the detection of hypoxic cells, a rabbit polyclonal antibody raised against a protein-bound, hexafluorinated, 2-nitroimidazole, designated CCI-103F, was used. The unmetabolized drug must first be injected into the dog to allow time for hypoxic metabolism and cellular binding to occur. For the detection of proliferating cells, a mouse monoclonal antibody raised against an endogenous nuclear protein, the "proliferating cell nuclear antigen," or PCNA, was used. This protein is expressed in most actively proliferating cells, but not in quiescent ones. An indirect immunostaining technique was used to visualize these markers in the tissue sections, and image analysis was used to estimate the area fraction of positive staining in representative, low magnification microscope fields.
Results: Tumors with both high and low hypoxic and proliferative area fractions have been identified. No systematic relationship between the prevalence of the two markers, nor of the relationship between tumor grade and proliferative fraction, could be established. Staining with the proliferation marker was more commonly found near blood vessels, but some "nests" of tumor cells apparently distant from vasculature contained many proliferating cells. Staining with the hypoxia marker tended to be distant from the vasculature and/or bordering regions of tumor necrosis, but some labeled cells appeared near blood vessels, and in the absence of necrosis. Staining of sequential sections, one with the proliferation marker and one with the hypoxia marker, indicated that the two cell populations overlapped to varying extents. Some incidental staining of canine normal tissues with both the proliferative and hypoxia markers was observed as well.
Conclusion: The immunochemical marker approach promises to be a useful tool to increase both our basic understanding of tumor physiology and the complex nature of tumor heterogeneity.
Similar articles
- Distribution of the hypoxia marker CCI-103F in canine tumors.
Cline JM, Thrall DE, Rosner GL, Raleigh JA. Cline JM, et al. Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):921-33. doi: 10.1016/0360-3016(94)90113-9. Int J Radiat Oncol Biol Phys. 1994. PMID: 8138446 - Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
Kennedy AS, Raleigh JA, Perez GM, Calkins DP, Thrall DE, Novotny DB, Varia MA. Kennedy AS, et al. Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):897-905. doi: 10.1016/s0360-3016(96)00539-1. Int J Radiat Oncol Biol Phys. 1997. PMID: 9128967 - Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors.
Raleigh JA, Zeman EM, Calkins DP, McEntee MC, Thrall DE. Raleigh JA, et al. Acta Oncol. 1995;34(3):345-9. doi: 10.3109/02841869509093987. Acta Oncol. 1995. PMID: 7779421 - Soft-tissue sarcomas in dogs: a review.
Ehrhart N. Ehrhart N. J Am Anim Hosp Assoc. 2005 Jul-Aug;41(4):241-6. doi: 10.5326/0410241. J Am Anim Hosp Assoc. 2005. PMID: 15995161 Review. - Canine Cutaneous and Subcutaneous Soft Tissue Sarcoma: An Evidence-Based Review of Case Management.
Hohenhaus AE, Kelsey JL, Haddad J, Barber L, Palmisano M, Farrelly J, Soucy A. Hohenhaus AE, et al. J Am Anim Hosp Assoc. 2016 Mar-Apr;52(2):77-89. doi: 10.5326/JAAHA-MS-6305. Epub 2016 Jan 25. J Am Anim Hosp Assoc. 2016. PMID: 26808432 Review.
Cited by
- DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response.
Freiberg RA, Hammond EM, Dorie MJ, Welford SM, Giaccia AJ. Freiberg RA, et al. Mol Cell Biol. 2006 Mar;26(5):1598-609. doi: 10.1128/MCB.26.5.1598-1609.2006. Mol Cell Biol. 2006. PMID: 16478982 Free PMC article. - Canine Cancer: Strategies in Experimental Therapeutics.
Thamm DH. Thamm DH. Front Oncol. 2019 Nov 15;9:1257. doi: 10.3389/fonc.2019.01257. eCollection 2019. Front Oncol. 2019. PMID: 31803625 Free PMC article. Review. - Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis.
Fenton BM, Paoni SF, Beauchamp BK, Ding I. Fenton BM, et al. Br J Cancer. 2002 Jun 5;86(11):1831-6. doi: 10.1038/sj.bjc.6600343. Br J Cancer. 2002. PMID: 12087474 Free PMC article. - Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology.
Nolan MW, Kent MS, Boss MK. Nolan MW, et al. Front Oncol. 2019 Nov 22;9:1291. doi: 10.3389/fonc.2019.01291. eCollection 2019. Front Oncol. 2019. PMID: 31824863 Free PMC article. Review. - [Intratumor pO2, S-phase fraction and p53 status in cervix carcinomas].
Hänsgen G, Hintner I, Krause V, Wohlrab W, Dunst J. Hänsgen G, et al. Strahlenther Onkol. 1997 Jul;173(7):385-7. doi: 10.1007/BF03038242. Strahlenther Onkol. 1997. PMID: 9265260 German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous